DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,099,008 | -26.8% | 86,400 | -19.0% | 0.00% | 0.0% |
Q2 2023 | $1,502,336 | -13.7% | 106,700 | -5.3% | 0.00% | 0.0% |
Q1 2023 | $1,741,215 | +9.7% | 112,700 | +16.4% | 0.00% | 0.0% |
Q4 2022 | $1,586,552 | -9.0% | 96,800 | +2.8% | 0.00% | 0.0% |
Q3 2022 | $1,743,000 | +60.1% | 94,200 | +13.8% | 0.00% | 0.0% |
Q2 2022 | $1,089,000 | +21.4% | 82,800 | -14.5% | 0.00% | 0.0% |
Q1 2022 | $897,000 | +2.5% | 96,800 | +8.0% | 0.00% | 0.0% |
Q4 2021 | $875,000 | -71.3% | 89,600 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $3,045,000 | -6.5% | 89,600 | +0.8% | 0.00% | 0.0% |
Q2 2021 | $3,255,000 | -14.2% | 88,900 | +5.1% | 0.00% | -33.3% |
Q1 2021 | $3,793,000 | -19.8% | 84,600 | +2.1% | 0.00% | 0.0% |
Q4 2020 | $4,731,000 | +12.1% | 82,900 | +0.7% | 0.00% | 0.0% |
Q3 2020 | $4,222,000 | -10.2% | 82,300 | +4.6% | 0.00% | -25.0% |
Q2 2020 | $4,700,000 | +130.6% | 78,700 | +59.0% | 0.00% | +100.0% |
Q1 2020 | $2,038,000 | -30.2% | 49,500 | +5.5% | 0.00% | -33.3% |
Q4 2019 | $2,919,000 | +88.2% | 46,900 | +2.6% | 0.00% | +50.0% |
Q3 2019 | $1,551,000 | +179.5% | 45,700 | +85.8% | 0.00% | +100.0% |
Q2 2019 | $555,000 | -12.7% | 24,600 | -10.2% | 0.00% | 0.0% |
Q1 2019 | $636,000 | +14.0% | 27,400 | +3.0% | 0.00% | 0.0% |
Q4 2018 | $558,000 | -43.9% | 26,600 | +3.5% | 0.00% | 0.0% |
Q3 2018 | $995,000 | -1.6% | 25,700 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,011,000 | – | 25,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |